project name: Urine And Kidney Proteomics
initiating country: The European Union
programme area: ESF – European Science Foundation contract type: ESF COST
contract/proposal/call number: BM0702
status: active
start date: January 2008 duration: 52 months projected finish date: May 2012
keywords: Kidney; Urine; Clinical Proteomics; Standardization
Note that the follow people may not represent the full extent of the consortium. FEAST has tried to identify the Australian participants, and their collaborators (or coordinator), within the project. Also note that Australian participation may not necessarily be on a formal level. Further details about the partners in this project can be found at the website listed below.
| name | organisation | state or country |
|---|---|---|
| Ακαδημίας Αθηνών | Greece | |
| TU Wien | Austria | |
| K.U.Leuven | Belgium | |
| Universiteit Antwerpen | Belgium | |
| Централна медицинска библиотека - София | Bulgaria | |
| University of Cyprus | Cyprus | |
| Univerzity obrany | Czech Republic | |
| UCPH | Denmark | |
| Helsingin yliopisto / Helsingfors universitet | Finland | |
| TKK | Finland | |
| АКАДЕМИЈАТА ПРЕД НОВИТЕ ПРЕДИЗВИЦИ НА ВРЕМЕТО | The Former Yugoslav Republic of Macedonia | |
| Inserm | France | |
| Georg-August Universität Göttingen | Germany | |
| Mosaiques diagnostics & therapeutics AG | Germany | |
| Dublin City University | Ireland | |
| SUN | Italy | |
| Politecnico di Milano | Italy | |
| Erasmus Universitair Medisch Centrum | The Netherlands | |
| UiO | Norway | |
| PAN | Poland | |
| WUM | Poland | |
| Универзитет у Београду | Serbia | |
| Fundación Jiménez Díaz | Spain | |
| ETH Zurick | Switzerland | |
| The University of Manchester | United Kingdom | |
| Baker IDI Heart and Diabetes Institute | VIC, Australia |
WWW: w3.cost.esf.org/index.php?id=212&action_number=BM0702
summary:
The main objective of the Action is to to catalyze translational research in kidney diseases via standardization in all aspects of urine and kidney proteomics analysis from specimen collection and databasing up to data processing and analysis.
Renal diseases constitute a major health threat in all societies. Proteomics is the large-scale analysis of the proteins of biological samples. Application of pro-teomics methodo-logies in the investigation of renal diseases will catalyze the development of optimal diagnostic and prognostic tests. Despite preliminary successful efforts, the interactions between the multidisciplinary teams of scientists working on kidney diseases and proteomics are still limited in Europe. EuroKUP will foster the generation of a strong and growing multi disciplinary network of scientists from at least 20 European countries, focusing on renal and urine proteomics.
The objectives of the Action focus on the identification of reference clinical centres for major kidney diseases and establishment of uniform clinical databases, standardization and optimization of procedures, integration of data to systems biology approaches and dissemination of information for application to diagnostic/prognostic procedures. Multiple scientific, technological and societal benefits to the European Union are expected, including but not limited to setting the urgently needed standards for clinical proteomics and translational research and improving the clinical situation in chronic renal diseases.